Dapagliflozin for Long COVID Syndrome | stella

Learn Find trials matched to me

Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy For Researchers Data Labs ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dapagliflozin for Long COVID Syndrome | stella

Back to COVID - 19 trials

Opening soon

Plain-English translation of NCT06907251 on ClinicalTrials.gov ↗ · Source last updated October 2026 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(1 site)

Canada

University of Ottawa Heart Institute, Ottawa, Ontario

Key details

Phase

Large-scale testing

Sponsor

Ottawa Heart Institute Research Corporation

Enrollment target

~192 participants

Started

December 2026

Primary completion

June 2028

Age range

18 Years and older

Last updated on clinicaltrials.gov in October 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Poppy Dr. Ian Paterson

Ottawa Heart Institute Research Corporation

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.